These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 12387726)
21. Inhibition of human beta-tryptase by Bowman-Birk inhibitor derived peptides: creation of a new tri-functional inhibitor. Scarpi D; McBride JD; Leatherbarrow RJ Bioorg Med Chem; 2004 Dec; 12(23):6045-52. PubMed ID: 15519150 [TBL] [Abstract][Full Text] [Related]
22. Protease-proteoglycan complexes of mouse and human mast cells and importance of their beta-tryptase-heparin complexes in inflammation and innate immunity. Stevens RL; Adachi R Immunol Rev; 2007 Jun; 217():155-67. PubMed ID: 17498058 [TBL] [Abstract][Full Text] [Related]
23. Mast cell tryptase: a review of its physiology and clinical significance. Payne V; Kam PC Anaesthesia; 2004 Jul; 59(7):695-703. PubMed ID: 15200544 [TBL] [Abstract][Full Text] [Related]
24. Human tryptase fibrinogenolysis is optimal at acidic pH and generates anticoagulant fragments in the presence of the anti-tryptase monoclonal antibody B12. Ren S; Lawson AE; Carr M; Baumgarten CM; Schwartz LB J Immunol; 1997 Oct; 159(7):3540-8. PubMed ID: 9317153 [TBL] [Abstract][Full Text] [Related]
25. X-ray structures of free and leupeptin-complexed human alphaI-tryptase mutants: indication for an alpha-->beta-tryptase transition. Rohr KB; Selwood T; Marquardt U; Huber R; Schechter NM; Bode W; Than ME J Mol Biol; 2006 Mar; 357(1):195-209. PubMed ID: 16414069 [TBL] [Abstract][Full Text] [Related]
26. A role for tryptase in the activation of human mast cells: modulation of histamine release by tryptase and inhibitors of tryptase. He S; Gaça MD; Walls AF J Pharmacol Exp Ther; 1998 Jul; 286(1):289-97. PubMed ID: 9655871 [TBL] [Abstract][Full Text] [Related]
27. Structural changes associated with the spontaneous inactivation of the serine proteinase human tryptase. Schechter NM; Eng GY; Selwood T; McCaslin DR Biochemistry; 1995 Aug; 34(33):10628-38. PubMed ID: 7654717 [TBL] [Abstract][Full Text] [Related]
28. Neutrophil myeloperoxidase is a potent and selective inhibitor of mast cell tryptase. Cregar L; Elrod KC; Putnam D; Moore WR Arch Biochem Biophys; 1999 Jun; 366(1):125-30. PubMed ID: 10334872 [TBL] [Abstract][Full Text] [Related]
29. Guinea pig lung tryptase. Localisation to mast cells and characterisation of the partially purified enzyme. McEuen AR; He S; Brander ML; Walls AF Biochem Pharmacol; 1996 Jul; 52(2):331-40. PubMed ID: 8694858 [TBL] [Abstract][Full Text] [Related]
30. Effects of human mast cell tryptase and eosinophil granule proteins on the kinetics of blood clotting. Samoszuk M; Corwin M; Hazen SL Am J Hematol; 2003 May; 73(1):18-25. PubMed ID: 12701115 [TBL] [Abstract][Full Text] [Related]
31. Modulation of enzymatic activity of human mast cell tryptase and chymase by protease inhibitors. He SH; Chen P; Chen HQ Acta Pharmacol Sin; 2003 Sep; 24(9):923-9. PubMed ID: 12956943 [TBL] [Abstract][Full Text] [Related]
32. Spontaneous inactivation of human tryptase involves conformational changes consistent with conversion of the active site to a zymogen-like structure. Selwood T; McCaslin DR; Schechter NM Biochemistry; 1998 Sep; 37(38):13174-83. PubMed ID: 9748324 [TBL] [Abstract][Full Text] [Related]
33. Histidines are critical for heparin-dependent activation of mast cell tryptase. Hallgren J; Bäckström S; Estrada S; Thuveson M; Pejler G J Immunol; 2004 Aug; 173(3):1868-75. PubMed ID: 15265919 [TBL] [Abstract][Full Text] [Related]
34. Potent, small-molecule inhibitors of human mast cell tryptase. Antiasthmatic action of a dipeptide-based transition-state analogue containing a benzothiazole ketone. Costanzo MJ; Yabut SC; Almond HR; Andrade-Gordon P; Corcoran TW; De Garavilla L; Kauffman JA; Abraham WM; Recacha R; Chattopadhyay D; Maryanoff BE J Med Chem; 2003 Aug; 46(18):3865-76. PubMed ID: 12930148 [TBL] [Abstract][Full Text] [Related]
35. Mast cell tryptase and chymase in chronic leg ulcers: chymase is potentially destructive to epithelium and is controlled by proteinase inhibitors. Huttunen M; Harvima IT Br J Dermatol; 2005 Jun; 152(6):1149-60. PubMed ID: 15948975 [TBL] [Abstract][Full Text] [Related]
36. Polycationic peptides as inhibitors of mast cell serine proteases. Lundequist A; Juliano MA; Juliano L; Pejler G Biochem Pharmacol; 2003 Apr; 65(7):1171-80. PubMed ID: 12663052 [TBL] [Abstract][Full Text] [Related]
37. Immunologic and physicochemical evidence for conformational changes occurring on conversion of human mast cell tryptase from active tetramer to inactive monomer. Production of monoclonal antibodies recognizing active tryptase. Schwartz LB; Bradford TR; Lee DC; Chlebowski JF J Immunol; 1990 Mar; 144(6):2304-11. PubMed ID: 2179409 [TBL] [Abstract][Full Text] [Related]
38. [Comparison of biochemical properties of human airway tryptase isolated from mucoid sputum with those of lung mast cell tryptase]. Yasuoka S; Tsuchihashi S; Kurokawa M; Terao T; Yoshinaga T; Kawano S; Takekawa Y; Nakayama T; Doi H; Ogawara M Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Jun; 34(6):678-84. PubMed ID: 8741534 [TBL] [Abstract][Full Text] [Related]
39. A novel heparin-dependent processing pathway for human tryptase. Autocatalysis followed by activation with dipeptidyl peptidase I. Sakai K; Ren S; Schwartz LB J Clin Invest; 1996 Feb; 97(4):988-95. PubMed ID: 8613553 [TBL] [Abstract][Full Text] [Related]
40. 1,2-Benzisothiazol-3-one 1,1-dioxide inhibitors of human mast cell tryptase. Combrink KD; Gülgeze HB; Meanwell NA; Pearce BC; Zulan P; Bisacchi GS; Roberts DG; Stanley P; Seiler SM J Med Chem; 1998 Nov; 41(24):4854-60. PubMed ID: 9822554 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]